Wei Liu, BSN Penn State Nursing N 870

Slides:



Advertisements
Similar presentations
INFECTIVE ENDOCARDITIS and valvular vegetations Alex Yartsev 30/03/2010.
Advertisements

INFLAMMATORY CONDITIONS OF HEART. LAYERS OF THE HEART.
Endocarditis usually refers to infection of the endocardium (infective endocarditis) The term can also include noninfective endocarditis, in which sterile.
Endocardite Infectieuse : Rôle de l’Echocardiographie
Microbiology Nuts & Bolts Session 3 Dr David Garner Consultant Microbiologist Frimley Park Hospital NHS Foundation Trust.
Sickle Cell Disease: Core Concepts for the Emergency Physician and Nurse Acute Chest Syndrome Spring 2013.
Infective endocarditis
When do you give prophylactic treatment in MVP?. Clinical approach to determination of the need for prophylaxis in patients with suspected MVP Prevention.
Infective Endocarditis By: Katie Walton. Infective Endocarditis An infection in the endothelium (the innermost lining of the heart). 2 to 4 people out.
Duke Criteria for Infective Endocarditis. Major Criteria 1.Positive Blood Culture Typical microorganism consistent with IE from 2 separate blood cultures,
Complications and principles of treatment of infective endocarditis incl. prognosis and antibiotic prophylaxis for endocarditis.
Infective Endocarditis. Is due to microbial infection of a heart valve, the lining of cardiac chamber or blood vessel, or a congenital anomaly (septal.
A Presentation by Alexis Anyang-Kusi & Renee Adonteng.
E NDOCARDITIS Lyndsey Sarpy. W HAT IS E NDOCARDITIS ? Endocarditis is an infection of the endocardium (inner lining of the heart)
Cardiac Pathology: Valvular Heart Disease, Cardiomyopathies and Other Stuff.
Infective edocarditis. Definition  an infection of the endocardium or vascular endothelium  it may occur as fulminating or acute infection  more commonly.
Infective Endocarditis. DEFINITION Infection or colonization of endocardium, heart valves and congenital heart defects by bacteria, rickettsiae and fungi.
ISKANDER AL-GITHMI, MD, FRCSC Consultant Cardiothoracic Surgeon Assistant Professor of Surgery King Abdulaziz University ISKANDER AL-GITHMI, MD, FRCSC.
ENDOCARDITIS The Etiology and the Laboratory Studies Reşat Özaras, MD, Professor, Infectious Diseases Dept.
Surgical outcome of native valve infective endocarditis in srinagarind hospital
Interventions for Clients with Cardiac Problems.
Copyright © 2010, 2007, 2004, 2000, Mosby, Inc., an affiliate of Elsevier Inc. All Rights Reserved. (Relates to Chapter 37, “Nursing Management: Inflammatory.
Dr. J. Satish Kumar, MD, Department of Basic & Medical Sciences, AUST General Medicine CVS Name:________________________________________ Infective Endocarditis.
Staphylococcus aureus bacteremia Sumathi Nambiar MD MPH Medical Team Leader Division of Anti-Infective Drug Products US Food and Drug Administration.
Infective Endocarditis
DR.ABDULELAH MOBEIREK FRCP(C). History  History of CAD, CHF, RHD, VHD, Hypertension  Symptoms: chest pain, dyspnea, edema,syncope  Any change in symptoms.
Valvular Heart Disease(VHD) in Primary Care Sayyadul (Sid) Siddiqui, MD Interventional Cardiologist CHI St. Vincent Heart Clinic Arkansas April 25, 2015.
Complications in Patients with Valvular Lesions Infective Endocarditis Heart Failure Dysrhythmias Pulmonary Hypertension Systemic Emboli Acute Rheumatic.
Albina Ongari, PharmD PGY-1 Pharmacy Resident
Infective Endocarditis A Disease in Disguise
Cardiac Pathology 3: Valvular Heart Disease, Cardiomyopathies and Other Stuff Kristine Krafts, M.D.
Pediatrics Julie K. Kuzin, MSN, RN, CPNP-PC/AC Endocarditis for the Advanced Practice Provider.
Harm from Invasive Devices Dr. Eleri Davies, Faculty Lead HCAI.
Infective endocarditis. Definitions, general information – Microbial infection of a heart valve (native or prosthetic ) or endothial lining of the heart.
Clinical Pharmacy.  Infective endocarditis (IE), a microbial infection of the heart valves or other endocardial tissue, usually is associated with an.
Infective Endocarditis
Infective endocarditis
HAP and VAP Guidelines Update
Endocarditis Tutoring
INFECTIVE ENDOCARDITIS
Infective Endocarditis
INFECTIVE ENDOCARDITIS
Infective endocarditis
Recent changes to NICE CG64:
INFECTIVE ENDOCARDITIS
Original slides courtesy of Dr. David M. Leder
Infective Endocarditis
Valvular Heart Disease, Cardiomyopathies,
INFECTIVE ENDOCARDITIS
What should dentists know about their patients with heart disease?
Therapeutics III Tutoring February 10th, 2016
Infective endocarditis
Update on Infective Endocarditis
Shuktika Nandkeolyar, PGY2 5/29/2017
INFECTIVE ENDOCARDITIS
Purpose Infective endocarditis (IE) which is an uncommon disease in pediatric patients can cause significant morbidity and mortality. IE is treated with.
Infective Endocarditis
Alterations of Cardiovascular Function
Dr Asmaa fathy abdellah hassan
INFECTIVE ENDOCARDITIS
INFECTIVE ENDOCARDITIS, MYOCARDITIS & PERICARDITIS
Infective endocarditis
CIED Infections Incidence, Diagnosis, Microbiology and Prognosis Dr. Adelqui Peralta EP Lab Director Boston VA Healthcare System West Roxbury Campus Assistant.
CLINICAL PROBLEM SOLVING
A.W. Karchmer  Clinical Microbiology and Infection 
Infective Endocarditis in Children by mbbsppt.com
Endocarditis is an inflammation of the endocardium, the membrane lining the chambers of the heart and covering the cusps of the heart valves. Infective.
Presentation transcript:

Wei Liu, BSN Penn State Nursing N 870 Endocarditis Wei Liu, BSN Penn State Nursing N 870

Introduction Endocarditis is inflammation of the inside lining of the heart chambers (endocardium) and heart valves It is commonly caused by bacteria infection, therefore we refer it to infective endocarditis (IE) IE is an uncommon, but not rare, disease. The annual incidence ranging from 3 to 7 per 100,000 person-years in the most contemporary population surveys. IE continues to be characterized by increased morbidity and mortality and is now the third or fourth most common life-threatening infection syndrome, after sepsis, pneumonia, and intra-abdominal abscess. (AHA, 2015)

Diagenosis Infection of the endocardial surface of the heart, usually involving heart valves or an intracardiac device Organisms: S. aureus, viridans streptococci, enterococci, and pseudomonas aeruginosa Complications: congestive heart failure, arterial emboli, myocardial infarction, myocardial abscesses death ( Sexton, 2015)

Pathogenesis Congenital or acquired heart condition Alteration of the valvular endothelium leading to depositions of platelets and fibrin Invasive procedures Microorganisms in the circulating blood stream colonize on the damaged valvular surface or preexisting sterile vegetation Microorganisms further propagate or enlarge the vegetation or cause systemic emboli Further impeding blood flow and incite inflammation that involves the vegetation and adjacent endothelium ( Sexton, 2015)

ROS PMH: prior endocarditis, prosthetic valve or cardiac device, valvular or congenital heart disease, rheumatic fever, IV drug use, IV lines, immunosuppression, recent dental/surgical procedure fever and chills fatigue nausea and vomiting weight lost and anorexia aching muscles and joints night sweats headaches shortness of breath and cough skin lesions hematuria (NHLBI, 2010)

Physical Exam General: chills, fatigue, and paleness vital signs: fever Eyes: Roth spots peripheral vascular: edema, clubbing, Splinter hemorrhages, Janeway lesions, and Osler's nodes Cardiovascular: onset/changed heart murmur, pleuritic pain Pulmonary: dyspnea, cough Gastrointestinal: splenomegaly, pain and fullness Neurological: confusion, sensory dysfunction

Diagnostic Tests blood cultures and echocardiography(TEE/TTE) Sed rate, C-reactive-protein, urinalysis, WBC modified Duke diagnosis criteria definite endocarditis: 2 major criteria, 1 major criterion and 3 minor criteria, or 5 minor criteria possible endocarditis: 1 major criterion and 1 minor criterion, or 3 minor criteria The sensitivity of the Modified Duke Criteria is 98-100%, and the specificity is 93% TEE has a substantially high sensitivity (76% to 100%) and specificity (94%), which is higher than TTE (Loeb et al, 2011 & Baddour, et al, 2015 )

Modified Duke Criteria

Differential Diagnosis Intravascular catheter infection Skin and soft tissue infection Cardiac device infection Prosthetic joint infection Sepsis And many more… This diagnosis of endocarditis (Red Flag) can be difficult to make, or the signs misleading, and there is a wide differential diagnosis to consider. (Sexton, 2015)

Treatment Antibiotic Therapy 4 to 6 weeks: based on the causative microorganism and its antibiotic susceptibility, and whether the involved valve is native or prosthetic. Initial empiric therapy- Vancomycin or Ampicillin/Sulbactam (Unasyn) plus an Aminoglycoside (plus rifampin in patients with prosthetic valves) Native Valve Endocarditis associates with staphylococci - Nafcillin and Gentamicin Prosthetic Valve Endocarditi associate MRSA or coagulase-negative staphylococci - Vancomycin, Rifampin and Gentamicin Vancomycin intolerance or resistant organisms -Linezolid or Daptomycin (Baddour, et al, 2015 )

Treatment Con't Surgical Therapy: patients with structural and functional damaged cardiac valves. Anticoagulation: controversial American Heart Association endocarditis treatment guidelines 2015: http://circ.ahajournals.org/content/early/2015/09/15/CIR.0000000000000296.full.pdf+html

Patient Education/Follow up intravenous catheters should be removed promptly after antibiotic therapy Monitor recurrent IE among intravenous drug abusers echocardiography should be performed to establish a new baseline monitored for complications such as valvular dysfunction, congestive heart failure, renal failure, and embolic phenomenon provide information about daily dental hygiene; regular visits to the dentist; and the need for antibiotic prophylaxis for certain procedures (Pierce et, al, 2012)

Outcomes most of patients are able to recover with appropriate antimicrobial therapy. The risk of embolization declines after institution of appropriate treatment. in-hospital mortality rate is 18 to 23%; the six-month mortality rate is 22 to 27% Complications: valvular dysfunction, congestive heart failure, renal failure, and embolic phenomenon (Spelman & Sexton, 2015) )

Reference: Baddour, L. M., Wilson, W. R., Bayer A. S., Fowler, V. G., Tleyjeh, I. M., Rybak M.J., et al. (2015). Infective endocarditis in adults: diagnosis, antimicrobial therapy, and management of complications: a scientific statement for healthcare professionals from the American Heart Association. Circulation. 132(15), P1435-86 Goroll, A. H., & Mulley, A. G. (2006). Primary care medicine: office evaluation and management of the adult patient. Philadelphia: Lippincott Williams & Wilkins. Loeb, M., Smaill, F., & Smieja, M. (2011). Evidence based infectious diseases. 2nd ed. Chichester: Wiley-Blackwel. National heart lung and blood institute (NHLBI). (2010). What is endocarditis. Retrieved from https://www.nhlbi.nih.gov/health/health-topics/topics/endo Pierce, D., Calkins, B. C., & Thornton, K. (2012). Infectious endocarditis: diagnosis and treatment. American Family Physician, 85(10), p981-986 Sexton, D. J. (2015) Pathogenesis of vegetation formation in infective endocarditis. UpToDate. Retrieved from http://www.uptodate.com/contents/pathogenesis-of-vegetation-formation-in-infective-endocarditis Spelman, D., & Sexton, D. (2015). Complications and outcome of infective endocarditis. UpToDate. Retrieved from http://www.uptodate.com/contents/complications-and-outcome-of-infective-endocarditis

Questions?